Neogenomics Inc (NEO)

Feb 26, 2026

Natera, NeoGenomics Unit End Patent Suit Over Lung Cancer Test - Bloomberg Law News

Feb 26, 2026

Feb 26, 2026

3 Reasons to Avoid NEO and 1 Stock to Buy Instead - Finviz

Feb 26, 2026

Feb 26, 2026

(NEO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Feb 26, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tu - PharmiWeb.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST Molecular Residual Disease Test - marketscreener.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics, Inc. Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - marketscreener.com

Feb 25, 2026

Feb 25, 2026

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types - The Joplin Globe

Feb 25, 2026

Feb 24, 2026

NeoGenomics outlines $793M–$801M 2026 revenue target as RaDaR ST and PanTracer initiatives gain traction - MSN

Feb 24, 2026

Feb 24, 2026

NeoGenomics, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Indicators - Markets Mojo

Feb 24, 2026

Feb 24, 2026

5 Insightful Analyst Questions From NeoGenomics's Q4 Earnings Call - Finviz

Feb 24, 2026

Feb 24, 2026

NeoGenomics, Inc. (NEO) Stock Analysis: A 47% Upside Potential in the Healthcare Diagnostics Sector - DirectorsTalk Interviews

Feb 24, 2026

Feb 24, 2026

Market Catalysts: What are Calix Incs technical support levelsMarket Trend Report & Verified Momentum Watchlists - baoquankhu1.vn

Feb 24, 2026

Feb 24, 2026

5 Insightful Analyst Questions From NeoGenomics’s Q4 Earnings Call - TradingView

Feb 24, 2026

Feb 23, 2026

NeoGenomics (NEO) Q4 2025 Earnings Call Transcript - AOL.com

Feb 23, 2026

Feb 23, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Feb 23, 2026

Feb 23, 2026

NeoGenomics (NASDAQ:NEO) Gains Traction In Nasdaq Index Mid-Cap Healthcare - Kalkine Media

Feb 23, 2026

Feb 22, 2026

Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - Yahoo Finance

Feb 22, 2026

Feb 21, 2026

NeoGenomics, Inc. $NEO Shares Bought by White Pine Capital LLC - MarketBeat

Feb 21, 2026

Feb 21, 2026

NeoGenomics, Inc. $NEO Stock Holdings Lifted by Aberdeen Group plc - MarketBeat

Feb 21, 2026

Feb 20, 2026

Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Feb 20, 2026

Feb 20, 2026

After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for NeoGenomics (NEO) - Finviz

Feb 20, 2026

Feb 19, 2026

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference - ACCESS Newswire

Feb 19, 2026

Feb 19, 2026

Why is NeoGenomics Inc. stock going upM&A Rumor & Free High Accuracy Swing Entry Alerts - mfd.ru

Feb 19, 2026

Feb 19, 2026

UBS Maintains Hold on NeoGenomics, Inc. (NEO) on Feb 18, 2026 - Meyka

Feb 19, 2026

Feb 19, 2026

Needham & Company LLC Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock - Defense World

Feb 19, 2026

Feb 19, 2026

NeoGenomics Q4 Earnings Call Highlights - Defense World

Feb 19, 2026

Feb 19, 2026

NeoGenomics Faces High-Stakes Risk as Test Reliability and Diagnostic Errors Threaten Reputation and Legal Exposure - TipRanks

Feb 19, 2026

Feb 18, 2026

NeoGenomics (NASDAQ:NEO) Trading Down 8.9%Should You Sell? - MarketBeat

Feb 18, 2026

Feb 18, 2026

NeoGenomics (NEO) Stock Drops After 2026 Outlook Misses ExpectationsNews and Statistics - IndexBox

Feb 18, 2026

Feb 18, 2026

Weekly Trades: Will ChoiceOne Financial Services Inc benefit from green energy policies2025 Performance Recap & Fast Moving Market Watchlists - baoquankhu1.vn

Feb 18, 2026

Feb 18, 2026

Why NeoGenomics (NEO) Shares Are Falling Today - Finviz

Feb 18, 2026

Feb 18, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 18, 2026

Feb 18, 2026

NeoGenomics to Participate in Upcoming Investor Conferences - The Joplin Globe

Feb 18, 2026

Feb 18, 2026

NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook - Finviz

Feb 18, 2026

Feb 18, 2026

NeoGenomics Q4 2025 slides: 11% revenue growth, RaDaR ST launch imminent - Investing.com South Africa

Feb 18, 2026

Feb 18, 2026

Labcorp (LH) Q4 2025 Earnings Call Transcript - AOL.com

Feb 18, 2026

Feb 18, 2026

NeoGenomics PanTracer Pro Launch Adds New Dimension To Growth Story - Yahoo Finance

Feb 18, 2026

Feb 17, 2026

NeoGenomics Earnings Call Signals Growth With Caveats - TipRanks

Feb 17, 2026

Feb 17, 2026

Needham raises Neogenomics stock price target on 2027 estimates - Investing.com Australia

Feb 17, 2026

Feb 17, 2026

Needham raises Neogenomics stock price target on 2027 estimates By Investing.com - Investing.com South Africa

Feb 17, 2026

Feb 17, 2026

NeoGenomics (NASDAQ:NEO) Shares Gap DownTime to Sell? - MarketBeat

Feb 17, 2026

Feb 17, 2026

NeoGenomics Q4 2025 Earnings Call Transcript - MarketBeat

Feb 17, 2026

Feb 17, 2026

NeoGenomics Reports Fourth Quarter and Full Year 2025 Results - BioSpace

Feb 17, 2026

Feb 17, 2026

NeoGenomics, Inc. (NEO) Investor Outlook: Assessing The 27.97% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

Earnings call transcript: NeoGenomics Q4 2025 earnings beat expectations - Investing.com

Feb 17, 2026

Feb 17, 2026

NeoGenomics shares fall over 5% despite earnings beat By Investing.com - Investing.com Canada

Feb 17, 2026

Feb 17, 2026

NeoGenomics: Q4 Earnings Snapshot - KVUE

Feb 17, 2026

Feb 17, 2026

NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Feb 17, 2026